CurrentCardio
Get Weekly

Topic · page 19 of 49

Heart failure & cardiomyopathies

HFrEF, HFmrEF, HFpEF, acute HF, cardiomyopathies (HCM, DCM, amyloidosis), myocarditis and inflammatory cardiomyopathy, devices for HF, HF prognosis

Briefs 721–760 of 1,928 placed here, newest publication first

Briefs in Heart failure & cardiomyopathies

Newest publication first

  1. Circ Heart Fail

    Association Between the 2022 AHA/ACC/HFSA Heart Failure Staging and Cardiovascular and Kidney Outcomes in Patients With Diabetes and Kidney Disease: A Post Hoc Analysis of the SCORED Randomized Controlled Trial

    Secondary analysis

  2. Circ Heart Fail

    Proteomic Signatures of Cardiac Dysfunction Among People With Diabetes: The Atherosclerosis Risk in Communities Study

    Diagnostic or prognostic study

  3. Circ Heart Fail

    Proteomics Profiling Reveals Circulating Biomarkers and Dysregulated Pathways in Transthyretin Amyloid Cardiomyopathy

    Case-control study

  4. ESC Heart Fail

    Association between cumulative exposure to cardiometabolic index and risk of heart failure: a prospective cohort study

    Cohort study

  5. ESC Heart Fail

    Bioimpedance-derived compartmental fluid status and prognosis in chronic heart failure

    Cohort study

  6. ESC Heart Fail

    Long-term prognostic value of cardiopulmonary exercise testing in patients with hypertrophic cardiomyopathy

    Cohort study

  7. ESC Heart Fail

    Metformin inhibits proliferation of residing fibroadipogenic progenitor cells from failing human hearts

    Mechanistic study

  8. Eur Heart J Cardiovasc Imaging

    Reappraising cardiac function with myocardial contraction fraction: normal values, disease detection, and prognostication

    Research article

  9. Heart

    Impact and prognostic implications of aortic stenosis across the heart failure spectrum: a cohort study

    Cohort study

  10. JACC Adv

    Body Mass Index, Left Ventricular Wall Stress, and NT-proBNP in Elderly Adults

    Research article

  11. JACC Adv

    Epidemiology of Hypertrophic Cardiomyopathy in the United States From 2016 to 2023

    Cohort study

  12. ESC Heart Fail

    Baseline characteristics in the TransitionCHF study: asymptomatic patients with heart failure and reduced ejection fraction

    Cohort study

  13. Eur J Heart Fail

    Prognostic value of early changes in NT-proBNP across left ventricular ejection fraction status in acute heart failure

    Cohort study

  14. ESC Heart Fail

    The adjusted ferritin inflammation index: a novel metric for predicting mortality in heart failure with reduced and mildly reduced ejection fraction

    Cohort study

  15. Heart

    Myocarditis and look-alikes: when the diagnosis matters

    Research article

  16. ESC Heart Fail

    Bridging the gap in heart failure management: the effect of a cross-disciplinary intervention on guidelines-directed medical therapy in primary care

    Cohort study

  17. ESC Heart Fail

    Optimising Transitions of Care and Long-Term Management in Heart Failure: A Scoping Review of Strategies and Models

    Research article

  18. JACC Adv

    Artificial Intelligence–Enhanced Electrocardiogram Models for Detection of Left Ventricular Dysfunction: A Comparison Study

    Meta-analysis

  19. JACC Adv

    Self- and Goal-Directed Valsalva Maneuver vs Exercise in Eliciting Left Ventricular Outflow Tract Obstruction

    Cohort study

  20. JACC Adv

    Clinical Characteristics and Outcomes of Patients With Takotsubo Syndrome Complicated With Acute Mitral Regurgitation

    Cohort study

  21. JACC Adv

    Spinal Stenosis and Carpal Tunnel Syndrome as Surrogates of Transthyretin Amyloid Cardiomyopathy

    Cohort study

  22. ESC Heart Fail

    Effect of mavacamten on sudden cardiac death risk scores in obstructive hypertrophic cardiomyopathy

    Cohort study

  23. ESC Heart Fail

    Efficacy of aficamten according to geographic location of patients with hypertrophic obstructive cardiomyopathy

    Randomised controlled trial

  24. ESC Heart Fail

    Predicting survival in patients with heart failure aged 80 years and older

    Diagnostic or prognostic study

  25. ESC Heart Fail

    Quantifying skeletal muscle energy metabolism during exercise in heart failure with preserved ejection fraction using in vivo 31P magnetic resonance spectroscopy

    Cohort study

  26. ESC Heart Fail

    Adaptive blood pressure–modulated atrial pacing in hypertensive HFpEF patients: a randomized, first-in-human study

    Randomised controlled trial

  27. ESC Heart Fail

    Arterio-venous gradient of active interleukin-18 is associated with diastolic dysfunction: a cross-sectional study

    Cross-sectional study

  28. ESC Heart Fail

    Effect of sodium-glucose cotransporter-2 inhibitors on haemoglobin and haematocrit levels in heart failure: a systematic review and meta-analysis

    Meta-analysis

  29. ESC Heart Fail

    Improved performance after neuromuscular electrical stimulation in hospitalized patients with severe heart failure

    Randomised controlled trial

  30. ESC Heart Fail

    The impact of country income level on the management of heart failure with preserved ejection fraction: an international survey

    Cross-sectional study

  31. Eur J Heart Fail

    Contemporary heart failure evidence in 2025: a joint summary of key trials from the European Journal of Heart Failure and ESC Heart Failure Journal

    Research article

  32. JACC Adv

    Sodium Glucose Co-Transporter 2 Inhibitors in Patients With Heart Failure and Transcatheter Aortic Valve Replacement

    Cohort study

  33. JACC Adv

    Multisite, External Validation of an AI-Enabled ECG Algorithm for Detection of Low Ejection Fraction

    Diagnostic or prognostic study

  34. ESC Heart Fail

    Impact of cannabidiol on myocardial recovery in patients with acute myocarditis: primary results of the ARCHER study

    Research article

  35. ESC Heart Fail

    Mortality and heart failure hospitalizations in heart failure with preserved ejection fraction compared to heart failure with reduced ejection fraction: a systematic review and meta-analysis

    Meta-analysis

  36. ESC Heart Fail

    Myocardial testosterone glucuronide and disease phenotypes in hypertrophic cardiomyopathy

    Cohort study

  37. ESC Heart Fail

    Rationale and design of the Pre-MYO project: a precision-medicine platform for myocarditis diagnosis and management

    Trial design

  38. ESC Heart Fail

    The possible impact of levosimendan infusions on clinical course of heart failure: the results of the LEIA-HF study

    Randomised controlled trial

  39. J Am Coll Cardiol

    Echocardiographic Diastolic Function Grading in HFpEF: Testing the Updated 2025 ASE Criteria

    Diagnostic or prognostic study

  40. J Am Coll Cardiol

    Heart Failure Quality of Care Among Asian Patients in the United States

    Cohort study

All 1,928 Briefs in ExploreShowing Briefs 721–760 of 1,928, newest first